부산대학교 도서관

Te Raa, G D; Derks, I A M; Navrkalova, V; Skowronska, A; Moerland, P D; van Laar, J; Oldreive, C; Monsuur, H; Trbusek, M; Malcikova, J; Lodén, M; Geisler, C H; Hüllein, J; Jethwa, A; Zenz, T; Pospisilova, S; Stankovic, T; van Oers, M H J; Kater, A P; Eldering, E

Leukemia

Davies N; Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham.; Francis T; Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham.; Oldreive C; Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham.; Azam M; Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham.; Wilson J; Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham.; Byrd PJ; Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham.; Burley M; Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham.; Sharma-Oates A; School of Biosciences, University of Birmingham, Birmingham.; Keane P; Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham.; Alatawi S; Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, UK; Department of Medical Laboratory Technology, Faculty of Applied Medical Sciences, University of Tabuk, Tabuk.; Higgs MR; Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham.; Rudzki Z; Department of Histopathology, University Hospitals Birmingham NHS Foundation Trust, Birmingham.; Ibrahim M; Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, UK; South Egypt Cancer Institute, Assiut University, Egypt.; Perry T; Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham.; Agathanggelou A; Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham.; Hewitt AM; Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham.; Smith E; Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham.; Bonifer C; Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham.; O'Connor M; Bioscience Oncology RandD, AstraZeneca, Cambridge.; Forment JV; Bioscience Oncology RandD, AstraZeneca, Cambridge.; Murray PG; School of Medicine, Bernal Institute, Health Research Institute and LDCRC, University of Limerick, Limerick, Ireland.; Fennell E; School of Medicine, Bernal Institute, Health Research Institute and LDCRC, University of Limerick, Limerick, Ireland.; Kelly G; Blood Cells and Bood Cancer Division, The Walter and Eliza Hall Institute of Medical Research, Victoria.; Chang C; Blood Cells and Bood Cancer Division, The Walter and Eliza Hall Institute of Medical Research, Victoria.; Stewart GS; Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham.; Stankovic T; Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham. t.stankovic@bham.ac.uk.; Kwok M; Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, UK; Centre for Clinical Haematology, Queen Elizabeth Hospital Birmingham, Birmingham. m.kwok@bham.ac.uk.; Taylor AM; Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham. a.m.r.taylor@bham.ac.uk.

Publisher: Ferrata Storti Foundation Country of Publication: Italy NLM ID: 0417435 Publication Model: Electronic Cited Medium: Internet ISSN: 1592-8721 (Electronic) Linking ISSN: 03906078 NLM ISO Abbreviation: Haematologica Subsets: MEDLINE

Skowronska, A.; Parker, A.; Ahmed, G.; Oldreive, C.; Davis, Z.; Richards, S.; Dyer, M.; Matutes, E.; Gonzalez, D.; Taylor, A.M.; Moss, P.; Thomas, P.; Oscier, D.; Stankovic, T.

Journal of Clinical Oncology. 30:4524-4532

Oldreive, C; Bradley, N; Bruckdorfer, R; Rice-Evans, C

Free Radical Research. 35:377-386

Oldreive, C; Rice-Evans, C

Free Radical Research. 35:215-231

Doherty, G.H.; Oldreive, C.; Harvey, J.

Neuroscience. 154(4):1297-1307

Thomas, A.; Perry, T.; Berhane, S.; Oldreive, C.; Zlatanou, A.; Williams, L.R; Weston, V.J; Stankovic, T.; Kearns, P.; Pors, K.; Grand, R.J; Stewart, G.S

Oncogene. June 18, 2015, p3336, 13 p.

te Raa, G D; Derks, I AM; Navrkalova, V; Skowronska, A; Moerland, P D; van Laar, J; Oldreive, C; Monsuur, H; Trbusek, M; Malcikova, J; Lodén, M; Geisler, C H; Hüllein, J; Jethwa, A; Zenz, T; Pospisilova, S; Stankovic, T; van Oers, M HJ; Kater, A P; Eldering, E

Leukemia. May 01, 2015 29(5):1133-1142

Stankovic, T.; Agathanggelou, A.; Oldreive, C.; Weston, V.; Moss, P.; Taylor, A.; Pratt, G.

Clinical Lymphoma Myeloma and Leukemia. 11:S243-S244

Oldreive, C. E.; Turner, C.; Devitt, A.; Shingler, W. H.; Gregory, C. D.

Immunology - Supplement. Dec 01, 2002 107 Suppl 1:10-10

Bland P; The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, UK.; Saville H; The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, UK.; Wai PT; The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, UK.; Curnow L; Division of Cancer Biology, The Institute of Cancer Research, London, UK.; Muirhead G; The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, UK.; Nieminuszczy J; Division of Cancer Biology, The Institute of Cancer Research, London, UK.; Ravindran N; The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, UK.; John MB; The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, UK.; Hedayat S; The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, UK.; Barker HE; The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, UK.; Stem Cells and Cancer Division, The Walter and Eliza Hall Institute of Medical Research, Melbourne, Victoria, Australia.; Wright J; Division of Cancer Biology, The Institute of Cancer Research, London, UK.; Yu L; Division of Cancer Biology, The Institute of Cancer Research, London, UK.; Mavrommati I; The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, UK.; Read A; The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, UK.; Peck B; The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, UK.; Translational Cancer Metabolism Team, Centre for Tumour Biology, Barts Cancer Institute, Cancer Research UK Centre of Excellence, Queen Mary University of London, Charterhouse Square, London, UK.; Allen M; Biological Services Unit, The Institute of Cancer Research, London, UK.; Gazinska P; The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, UK.; Pemberton HN; The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, UK.; The Cancer Research UK Gene Function Laboratory, The Institute of Cancer Research, London, UK.; Gulati A; The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, UK.; The Cancer Research UK Gene Function Laboratory, The Institute of Cancer Research, London, UK.; Nash S; The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, UK.; Noor F; The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, UK.; Guppy N; The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, UK.; Roxanis I; The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, UK.; Pratt G; University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK.; Oldreive C; Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, UK.; Stankovic T; Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, UK.; Barlow S; Liverpool Ocular Oncology Research Group, Department of Molecular and Clinical Cancer Medicine, University of Liverpool, Liverpool, UK.; Kalirai H; Liverpool Ocular Oncology Research Group, Department of Molecular and Clinical Cancer Medicine, University of Liverpool, Liverpool, UK.; Coupland SE; Liverpool Ocular Oncology Research Group, Department of Molecular and Clinical Cancer Medicine, University of Liverpool, Liverpool, UK.; Broderick R; Division of Cancer Biology, The Institute of Cancer Research, London, UK.; Alsafadi S; Inserm U830, PSL University, Institut Curie, Paris, France.; Houy A; Inserm U830, PSL University, Institut Curie, Paris, France.; Stern MH; Inserm U830, PSL University, Institut Curie, Paris, France.; Pettit S; The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, UK.; The Cancer Research UK Gene Function Laboratory, The Institute of Cancer Research, London, UK.; Choudhary JS; Division of Cancer Biology, The Institute of Cancer Research, London, UK.; Haider S; The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, UK.; Niedzwiedz W; Division of Cancer Biology, The Institute of Cancer Research, London, UK.; Lord CJ; The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, UK.; The Cancer Research UK Gene Function Laboratory, The Institute of Cancer Research, London, UK.; Natrajan R; The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, UK. rachael.natrajan@icr.ac.uk.

Publisher: Nature Pub. Co Country of Publication: United States NLM ID: 9216904 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1546-1718 (Electronic) Linking ISSN: 10614036 NLM ISO Abbreviation: Nat Genet Subsets: MEDLINE

Pratt G; University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK.; Yap C; Cancer Research UK Clinical Trials Unit, University of Birmingham, Birmingham, UK.; Oldreive C; Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, UK.; Slade D; Cancer Research UK Clinical Trials Unit, University of Birmingham, Birmingham, UK.; Bishop R; Cancer Research UK Clinical Trials Unit, University of Birmingham, Birmingham, UK.; Griffiths M; West Midlands Regional Genetics Laboratory, Birmingham, UK.; Dyer MJS; Department of Cancer Studies, University of Leicester, Leicester, UK.; Fegan C; Cardiff and Vale University Health board, University Hospital of Wales, Cardiff, UK.; Oscier D; Royal Bournemouth and Christchurch NHS Foundation Trust, Bournemouth, UK.; Pettitt A; The Royal Liverpool and Broadgreen University Hospitals NHS Trust, Liverpool, UK.; Matutes E; Royal Marsden NHS Foundation Trust, London, UK.; Devereux S; King's College Hospital NHS Foundation Trust, London, UK.; Allsup D; Hull York Medical School, Hull, UK.; Bloor A; The Christie NHS Foundation Trust, Manchester, UK.; Hillmen P; St James University Hospital, Leeds Teaching Hospitals NHS Trust, Leeds, UK.; Follows G; Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.; Rule S; Plymouth Hospitals NHS Trust, Plymouth, UK.; Moss P; University of Birmingham, Birmingham, UK.; Stankovic T; Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, UK.

Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 0372544 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1365-2141 (Electronic) Linking ISSN: 00071048 NLM ISO Abbreviation: Br J Haematol Subsets: MEDLINE

Da Costa, D.; Agathanggelou, A.; Perry, T.; Weston, V.; Petermann, E.; Zlatanou, A.; Oldreive, C.; Wei, W.; Stewart, G.; Longman, J.; Smith, E.; Kearns, P.; Knapp, S.; Stankovic, T.

Blood Cancer J

Devitt, Andrew; Parker, Kate G; Ogden, Carol Anne; Oldreive, Ceri; Clay, Michael F; Melville, Lynsey A; Bellamy, Christopher O; Lacy-Hulbert, Adam; Gangloff, Sophie C; Goyert, Sanna M; Gregory, Christopher D

J Cell Biol
Devitt, A, Parker, K G, Ogden, C A, Oldreive, C, Clay, M F, Melville, L A, Bellamy, C O, Lacy-Hulbert, A, Gangloff, S C, Goyert, S M & Gregory, C D 2004, ' Persistence of apoptotic cells without autoimmune disease or inflammation in CD14-/-mice ', Journal of Cell Biology, vol. 167, no. 6, pp. 1161-70 . https://doi.org/10.1083/jcb.200410057

C, Oldreive; K, Zhao; G, Paganga; B, Halliwell; C, Rice-Evans

Chemical Research in Toxicology. 11:1574-1579

A, Devitt; S, Pierce; C, Oldreive; W H, Shingler; C D, Gregory

Cell Death & Differentiation. 10:371-382

Kennedy E; Department of Clinical and Experimental Medicine, Brighton and Sussex Medical School, Falmer, United Kingdom.; Coulter E; Centre for Genomics and Computational Biology, Barts Cancer Institute, Queen Mary University of London, London, United Kingdom.; Department of Haemato-Oncology, Division of Cancer Studies, Faculty of Life Sciences & Medicine, King's College London, London, United Kingdom.; Halliwell E; UCL Great Ormond Street Institute of Child Health, London, United Kingdom.; Profitos-Peleja N; Lymphoma Translational Group, Josep Carreras Leukaemia Research Institute, Badalona, Spain.; Walsby E; Cardiff CLL Research Group, Institute of Cancer & Genetics, School of Medicine, Cardiff University, Cardiff, United Kingdom.; Clark B; Molecular Pathology Laboratory, King's College Hospital, London, United Kingdom.; Phillips EH; Department of Haemato-Oncology, Division of Cancer Studies, Faculty of Life Sciences & Medicine, King's College London, London, United Kingdom.; Division of Cancer Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, United Kingdom.; Burley TA; Department of Clinical and Experimental Medicine, Brighton and Sussex Medical School, Falmer, United Kingdom.; Mitchell S; Department of Clinical and Experimental Medicine, Brighton and Sussex Medical School, Falmer, United Kingdom.; Devereux S; Department of Haemato-Oncology, Division of Cancer Studies, Faculty of Life Sciences & Medicine, King's College London, London, United Kingdom.; Fegan CD; Cardiff CLL Research Group, Institute of Cancer & Genetics, School of Medicine, Cardiff University, Cardiff, United Kingdom.; Jones CI; Department of Primary Care and Public Health, Brighton and Sussex Medical School, Falmer, United Kingdom.; Johnston R; Department of Haematology, Brighton and Sussex University Hospital Trust, Brighton, United Kingdom.; Chevassut T; Department of Clinical and Experimental Medicine, Brighton and Sussex Medical School, Falmer, United Kingdom.; Department of Haematology, Brighton and Sussex University Hospital Trust, Brighton, United Kingdom.; Schulz R; German Cancer Research Centre (DKFZ), Heidelberg, Germany.; Seiffert M; German Cancer Research Centre (DKFZ), Heidelberg, Germany.; Agathanggelou A; Institute of Cancer and Genomic Sciences, College of Medical and Dental Sciences, University of Birmingham, Birmingham, United Kingdom; and.; Oldreive C; Institute of Cancer and Genomic Sciences, College of Medical and Dental Sciences, University of Birmingham, Birmingham, United Kingdom; and.; Davies N; Institute of Cancer and Genomic Sciences, College of Medical and Dental Sciences, University of Birmingham, Birmingham, United Kingdom; and.; Stankovic T; Institute of Cancer and Genomic Sciences, College of Medical and Dental Sciences, University of Birmingham, Birmingham, United Kingdom; and.; Liloglou T; Molecular and Clinical Cancer Medicine, Institute of Systems, Molecular and Integrative Biology, University of Liverpool, Liverpool, United Kingdom.; Pepper C; Department of Clinical and Experimental Medicine, Brighton and Sussex Medical School, Falmer, United Kingdom.; Pepper AGS; Department of Clinical and Experimental Medicine, Brighton and Sussex Medical School, Falmer, United Kingdom.

Publisher: Elsevier Country of Publication: United States NLM ID: 7603509 Publication Model: Print Cited Medium: Internet ISSN: 1528-0020 (Electronic) Linking ISSN: 00064971 NLM ISO Abbreviation: Blood Subsets: MEDLINE

Kwok M; Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, United Kingdom.; Centre for Clinical Haematology, Queen Elizabeth Hospital Birmingham, Birmingham, United Kingdom.; Haematological Malignancy Diagnostic Service, St. James's University Hospital, Leeds, United Kingdom.; Oldreive C; Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, United Kingdom.; Rawstron AC; Haematological Malignancy Diagnostic Service, St. James's University Hospital, Leeds, United Kingdom.; Goel A; Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, United Kingdom.; Centre for Computational Biology, University of Birmingham, Birmingham, United Kingdom.; Papatzikas G; Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, United Kingdom.; Centre for Computational Biology, University of Birmingham, Birmingham, United Kingdom.; Jones RE; Division of Cancer and Genetics, School of Medicine, Cardiff University, Cardiff, United Kingdom.; Drennan S; Cancer Sciences Unit, University of Southampton, Southampton, United Kingdom.; Agathanggelou A; Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, United Kingdom.; Sharma-Oates A; Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, United Kingdom.; Centre for Computational Biology, University of Birmingham, Birmingham, United Kingdom.; Evans P; Haematological Malignancy Diagnostic Service, St. James's University Hospital, Leeds, United Kingdom.; Smith E; Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, United Kingdom.; Dalal S; Haematological Malignancy Diagnostic Service, St. James's University Hospital, Leeds, United Kingdom.; Mao J; Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, United Kingdom.; Hollows R; Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, United Kingdom.; Gordon N; Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, United Kingdom.; Hamada M; Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, United Kingdom.; Davies NJ; Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, United Kingdom.; Parry H; Centre for Clinical Haematology, Queen Elizabeth Hospital Birmingham, Birmingham, United Kingdom.; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, United Kingdom.; Beggs AD; Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, United Kingdom.; Munir T; Haematological Malignancy Diagnostic Service, St. James's University Hospital, Leeds, United Kingdom.; Moreton P; Department of Haematology, Pinderfields General Hospital, Wakefield, United Kingdom.; Paneesha S; Department of Haematology, Birmingham Heartlands Hospital, Birmingham, United Kingdom; and.; Pratt G; Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, United Kingdom.; Centre for Clinical Haematology, Queen Elizabeth Hospital Birmingham, Birmingham, United Kingdom.; Taylor AMR; Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, United Kingdom.; Forconi F; Cancer Sciences Unit, University of Southampton, Southampton, United Kingdom.; Baird DM; Division of Cancer and Genetics, School of Medicine, Cardiff University, Cardiff, United Kingdom.; Cazier JB; Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, United Kingdom.; Centre for Computational Biology, University of Birmingham, Birmingham, United Kingdom.; Moss P; Centre for Clinical Haematology, Queen Elizabeth Hospital Birmingham, Birmingham, United Kingdom.; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, United Kingdom.; Hillmen P; Haematological Malignancy Diagnostic Service, St. James's University Hospital, Leeds, United Kingdom.; Section of Experimental Haematology, University of Leeds, Leeds, United Kingdom.; Stankovic T; Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, United Kingdom.

Publisher: Elsevier Country of Publication: United States NLM ID: 7603509 Publication Model: Print Cited Medium: Internet ISSN: 1528-0020 (Electronic) Linking ISSN: 00064971 NLM ISO Abbreviation: Blood Subsets: MEDLINE

Oldreive, C; Rice-Evans, C

FREE RADICAL RESEARCH; 2001, 35 3, p215-p231, 17p.

Parry HM; Institute of Immunology and Immunotherapy, College of Medical and Dental Sciences, University of Birmingham, B15 2TT, UK.; Stevens T; Institute of Immunology and Immunotherapy, College of Medical and Dental Sciences, University of Birmingham, B15 2TT, UK.; Oldreive C; Institute of Cancer and Genomic Sciences, College of Medical and Dental Science, University of Birmingham, B15 2TT, UK.; Zadran B; Institute of Immunology and Immunotherapy, College of Medical and Dental Sciences, University of Birmingham, B15 2TT, UK.; McSkeane T; Institute of Cancer and Genomic Sciences, College of Medical and Dental Science, University of Birmingham, B15 2TT, UK.; Rudzki Z; Department of Haematology, Birmingham Heartlands Hospital, Birmingham, B9 5SS, UK.; Paneesha S; Department of Haematology, Birmingham Heartlands Hospital, Birmingham, B9 5SS, UK.; Chadwick C; Biomedical Services Unit, University of Birmingham, B15 2TT, UK.; Stankovic T; Institute of Cancer and Genomic Sciences, College of Medical and Dental Science, University of Birmingham, B15 2TT, UK.; Pratt G; Department of Haematology, Birmingham Heartlands Hospital, Birmingham, B9 5SS, UK.; Zuo J; Institute of Immunology and Immunotherapy, College of Medical and Dental Sciences, University of Birmingham, B15 2TT, UK.; Moss P; Institute of Immunology and Immunotherapy, College of Medical and Dental Sciences, University of Birmingham, B15 2TT, UK.

Publisher: Impact Journals Country of Publication: United States NLM ID: 101532965 Publication Model: Print Cited Medium: Internet ISSN: 1949-2553 (Electronic) Linking ISSN: 19492553 NLM ISO Abbreviation: Oncotarget Subsets: MEDLINE